{"title":"If you care about women's health, perhaps you should care about the risks of direct marketing of tamoxifen to consumers.","authors":"N Press, W Burke","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"3 2","pages":"98-103"},"PeriodicalIF":0.0,"publicationDate":"2000-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21755788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"When should we stop screening?","authors":"J S Rich, W C Black","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>Although the age at which screening should be started is the subject of considerable debate, the question of when to stop has received little attention.</p><p><strong>Count: </strong>Days of life lost by stopping screening at various ages.</p><p><strong>Calculations: </strong>For each of three types of cancer (breast, cervical, and colon), we used life tables to calculate life expectancy at various ages for stopping screening and for continuing screening until death. The days of life lost by stopping screening is the difference in life expectancy between the two life tables for a specified age.</p><p><strong>Data sources: </strong>All-cause and cancer-specific mortality were obtained from the National Center for Health Statistics and Surveillance Epidemiology and End Results Survey (SEER). ASSUMPTIONS ABOUT BENEFIT: On the basis of randomized trial data, we used a 30% reduction in cancer-specific mortality for breast and colon cancer screening. Because there are no comparable data for cervical cancer, we assumed a 30% reduction in the mortality rate for the \"best-guess\" analysis and a 70% reduction in the mortality rate for the \"best-case\" analysis. We assumed that these benefits persisted for the elderly. ASSUMPTIONS ABOUT HARM: We assumed that there was no harm with screening.</p><p><strong>Results: </strong>Given a starting age of 50 years, screening throughout life has a maximum potential life expectancy benefit of 43 days for breast cancer and 28 days for colon cancer. The average 75-year-old who stops either mammography or fecal occult blood testing would give up a maximum of 9 days. By stopping at age 80, she would give up a maximum of 5 days. Given a starting age of 20, Pap smear screening has a maximum potential benefit of 47 days in the best-case analysis and 7 days in the best-guess analysis. The average 75-year-old who forgoes Pap smear screening would give up a maximum of 3 days (best case) or 0.5 days (best guess). By stopping at age 80, she would give up a maximum of 1.5 days and 0.2 days, respectively.</p><p><strong>Conclusions: </strong>Even assuming that the mortality reduction with screening persists in the elderly, 80% of the benefit is achieved before 75 years of age for breast cancer, 80 years for colon cancer, and 65 years for cervical cancer. The small benefit of screening in the elderly may be outweighed by the harms: anxiety, additional testing, and unnecessary treatment.</p>","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"3 2","pages":"78-84"},"PeriodicalIF":0.0,"publicationDate":"2000-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21755779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Grading the evidence for diabetes performance measures.","authors":"S H Roman, S B Silberzweig, A L Siu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>Grading scientific evidence is a critical step in developing practice guidelines and quality performance measures.</p><p><strong>General question: </strong>What is the most useful way to grade evidence?</p><p><strong>Specific question: </strong>How should we grade the recommended clinical practices for patients with diabetes?</p><p><strong>Standard approach: </strong>Hierarchical grading systems (e.g., grades I, II, and III), such as that used by the U.S. Preventive Services Task Force, have traditionally been used to rank the research designs of studies that support a particular clinical practice.</p><p><strong>Potential difficulties: </strong>Many studies that support the clinical practices of diabetes care do not clearly conform to the categories traditionally used in hierarchical grading systems. As a result, there is a tendency to inaccurately characterize the level of evidence, leading to the phenomenon of evidence inflation or evidence deflation. To avoid exaggerating the evidence, important sources of information may be excluded, resulting in an understatement of the available supporting evidence.</p><p><strong>Alternate approach: </strong>This paper offers a more descriptive typologic system that uses the study design and an explanatory modifier to grade the evidence supporting the clinical practices of diabetes care. The study grades are randomized, controlled trial (RCT); RCT-embedded component; RCT-treatment only; RCT-different population; observational study-risk factor; and expert opinion. Using this grading system, the authors were able to more accurately describe the best available evidence supporting the clinical practices of diabetes care.</p>","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"3 2","pages":"85-91"},"PeriodicalIF":0.0,"publicationDate":"2000-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21755780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"How patients with diabetes perceive their risk for major complications.","authors":"D Meltzer, B Egleston","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>To educate patients with diabetes about their illness and to motivate these patients to pursue intensive treatment, physicians often inform them about their risk for serious complications. However, little is known about patient perceptions of these risks.</p><p><strong>Objective: </strong>To compare patient perceptions of risk for major complications of diabetes with actual risk for these complications.</p><p><strong>Design: </strong>Structured interviews were done to obtain the patient's estimate of their risk for complications. To generate estimates of actual risk for each patient, we used a simulation model based on the Diabetes Control and Complications Trial (DCCT).</p><p><strong>Setting: </strong>Four university-affiliated diabetes clinics in the midwestern United States.</p><p><strong>Patients: </strong>139 patients with type 1 diabetes mellitus.</p><p><strong>Main outcome measures: </strong>Probability of blindness, end-stage renal disease (ESRD), and lower-leg amputation over 20 years.</p><p><strong>Results: </strong>Participants were young (mean age, 30 years) and reported having had diabetes for an average of 15 years. Seventy-nine percent reported their current diabetic therapy to be \"intensive.\" Ninety-eight percent had completed high school, and 51% were college graduates. The patients' estimates of their risks far exceeded the DCCT estimates for all three complications. The mean patient estimate of the risk for blindness was 31.6% (DCCT estimate, 17.0%), of the risk for ESRD was 33.7% (DCCT estimate, 8.7%), and of the risk for amputation was 25.1% (DCCT estimate, 1.9%). Similarly, patients overestimated the benefit of intensive therapy. They estimated, on average, that intensive therapy would result in a 17.0% absolute risk reduction for blindness (DCCT estimate, 12.2%), an 18.1% risk reduction for ESRD (DCCT estimate, 7.0%), and a 14.2% risk reduction for amputation (DCCT estimate, 1.2%).</p><p><strong>Conclusion: </strong>Patients with diabetes overestimated their risk for major complications and the benefits of intensive treatment.</p>","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"3 1","pages":"7-15"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21635250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risky business.","authors":"H G Welch","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"3 1","pages":"45-6"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21636255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Alternative explanations for poor report card performance.","authors":"R Sorokin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>Many managed care organizations grade physician groups with \"report cards\" developed from administrative data sets and chart reviews.</p><p><strong>Objective: </strong>To investigate the accuracy of five report cards on a single group practice.</p><p><strong>Design: </strong>Determination of report card accuracy by using the practice capitation list and a review of the patients' medical records.</p><p><strong>Setting: </strong>Academic practice in Philadelphia, Pennsylvania (19 physicians), evaluated with five report cards by two capitated health plans between 1994 and 1997.</p><p><strong>Results: </strong>Four major problems were uncovered. First, four of the five report cards included patients who were enrolled in our practice for only a portion of the reporting year (for the four report cards, the proportion of partial-year enrollees was 8%, 15%, 23%, and 100%). Second, there was a considerable number of false-positive diagnoses in the administrative algorithms. Eight of the 61 patients labeled with hypertension did not have this condition (error rate, 14%). Other error rates were 44% for coronary artery disease, 50% for congestive heart failure, 33% for atrial fibrillation, and 0% for diabetes. Third, the administrative data often failed to capture laboratory data. Laboratory performance measures for patients with diabetes (hemoglobin A1c and cholesterol measurement and screening for microalbuminuria) were 3 to 10 times higher when assessed by chart review. Finally, the uniformly small sample sizes used in the report cards make the estimates of performance imprecise. No report card reported 95% CIs.</p><p><strong>Conclusion: </strong>Five report cards on a group practice contained methodologic problems that led to systematic underestimation of the practice's performance. Larger surveys are needed to determine the accuracy of report cards in current use.</p>","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"3 1","pages":"25-30"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21636251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Radiologic tests after a new diagnosis of breast cancer.","authors":"R O Dillman, S Chico","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>Radiologic tests may be overused in the staging of newly diagnosed breast cancer.</p><p><strong>Objective: </strong>To determine the frequency with which radiologic tests are used in women with newly diagnosed breast cancer and the yield of such tests in these patients.</p><p><strong>Methods: </strong>We used the tumor registry database from the Hoag Cancer Center, Newport Beach, California, to identify and classify the disease stage of all patients with breast cancer who received a diagnosis from or were initially treated by Hoag staff from 1990 to 1994. After excluding patients with unknown tumor (T) and lymph node (N) status, we retrospectively determined the frequency with which radiologic tests were performed within 4 weeks of diagnosis and the proportion of these tests that detected metastatic disease.</p><p><strong>Results: </strong>A total of 1910 radiologic tests, including 646 bone scans, 637 chest radiographs, and 627 other tests, were obtained in 1167 patients with a known TN status. Radiologic tests were performed in 42% of patients with carcinoma in situ, but none of the 183 tests detected metastases. Eight hundred twenty-eight radiologic tests were performed in patients who were classified as having stage I disease on the basis of TN criteria. Only three of these tests (0.4%) detected metastatic disease, and all three were performed in one patient with bone pain. For patients who were classified as having stage IIA, stage IIB, or stage III disease on the basis of TN criteria, 5 of 410 tests (1.2%), 20 of 294 tests (6.8%), and 33 of 195 tests (17%), respectively, yielded positive results.</p><p><strong>Conclusions: </strong>Radiologic staging tests are overused in patients with newly diagnosed, early-stage breast cancer. These tests are unnecessary in patients with breast cancer who have 1) a tumor that is 5 cm in diameter or smaller, 2) no axillary lymphadenopathy on physical examination, 3) normal results on blood chemistry tests, and 4) no symptoms or physical findings of metastatic disease.</p>","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"3 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21636249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M P Jans, F G Schellevis, W Van Hensbergen, J T van Eijk
{"title":"Improving general practice care of patients with asthma or chronic obstructive pulmonary disease: evaluation of a quality system.","authors":"M P Jans, F G Schellevis, W Van Hensbergen, J T van Eijk","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>During the past decade, several guidelines on the management of chronic obstructive pulmonary disease and asthma have been developed. However, strategies for implementing these guidelines have not been systematically evaluated.</p><p><strong>Objective: </strong>To test a quality system intended to improve general practitioners' compliance with recently established guidelines.</p><p><strong>Design: </strong>Before-after study with concurrent controls. UNIT OF ANALYSIS: 19 general medical practices in the Netherlands (14 intervention practices and 5 control practices).</p><p><strong>Intervention: </strong>A quality system with five components: identification of barriers, documentation, education, feedback, and peer review.</p><p><strong>Patients: </strong>Outpatients 16 to 70 years of age with asthma or chronic obstructive pulmonary disease.</p><p><strong>Measurements: </strong>The number of consultations for respiratory symptom monitoring, measurement of peak expiratory flow rate, prescription of anti-inflammatory agents, monitoring of medication compliance and inhalation technique, and influenza vaccination.</p><p><strong>Results: </strong>The percentage of patients who had two or more consultations per year increased significantly in the intervention practices (median, 27% of patients before the intervention vs 82% of patients after the intervention; P < 0.01), as did the percentage of patients who had at least one measurement of peak expiratory flow rate (median, 10% of patients before the intervention vs 84% of patients after the intervention; P < 0.01). The percentage of patients who received a prescription for anti-inflammatory agents did not increase significantly. No significant changes were seen in the control practices. Physicians in the intervention practices were more likely to monitor medication compliance and inhalation technique. No difference was found in frequency of influenza vaccination.</p><p><strong>Conclusion: </strong>The quality system improved guideline compliance in some areas but not in others.</p>","PeriodicalId":79873,"journal":{"name":"Effective clinical practice : ECP","volume":"3 1","pages":"16-24"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21636250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}